Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.

Slides:



Advertisements
Similar presentations
Susan Burner Bankowski, M.S., J.D. Chair, OHSU IRB
Advertisements

Gerald Treiman, IRB Chair John Stillman, IRB Director Maureen Brinkman, IRB Administrator Ann Johnson, IRB Administrator.
Safety Reporting IN Clinical Trials
What is a Data and Safety Monitoring Plan and how do I get one? Presented by Office of Human Research Protection.
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
Reporting Unanticipated Problems Involving Risk to Subjects or Others and Adverse Events WFUHS Policy/Procedure Effective Date 6/1/07 Wendy Murray Monitoring.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
1 © Huron Consulting Group Inc. All rights reserved. Huron is a management consulting firm and not a CPA firm, and does not provide attest services, audits,
Capturing and Reporting Adverse Events in Clinical Research
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
Director, Investigator Support & Integration Services, OCTRI
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Office of Research Oversight VHA Handbook Research Conducted by VHA Program Office Employees Effective May 1, 2012 October 28, 2011.
HRPP Policies & Forms Created/Revised for AAHRPP.
Reality vs Urban Myth: The Truth About Regulations
Defining Unanticipated Problems Involving Risks to Subjects or Others (UPIRSO)
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
Who’s the Boss? Faculty Advisor or Principal Investigator Supervision versus Student Investigator or Study Coordinator Responsibilities Gwenn Snow, MS,
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
SERIOUS ADVERSE EVENTS REPORTING Elizabeth Dayag IRB Administrator Naval Medical Center Portsmouth.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Unanticipated Problems Potentially Involving Risks to Subjects or Others Research Protections Office Serving UVM and FAHC Updated April 2012.
New Adverse Event Reporting Policy Effective September 1, 2007.
Reporting Adverse Events and Unanticipated Problems to the UAB IRB Policy and Procedure Change September 22, 2006 Amanda G. Murphy, RN, CIP Assistant Director,
Sara Brand Associate Director Research Compliance Administration.
EMORY INSTITUTIONAL REVIEW BOARD VERSION Unanticipated Problems, Protocol Deviations and Non-Compliance.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
Adverse Event/Unanticipated Problems Policy and Procedures November 2007.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Office of Research Oversight 1 VHA Handbook Research Compliance Reporting Requirements Revised May 21, 2010 (Presentation prepared for HRPP 101,
VHA Handbook “Research Compliance Reporting Requirements” Version: June 15, 2015 ORO Presentation: July 14 and 16, 2015.
Understanding Unanticipated Problems (UPs) Elizabeth Ness, RN, MS Director, Staff Development Office of the Clinical Director Center for Cancer Research,
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
Office of Research Oversight 1 VHA Handbook Research Compliance Reporting Requirements HRPP September
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Continuing Review Presented by: Karen Jeans, PhD, CCRN, CIP Program Analyst, COACH.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
Investigational Devices and Humanitarian Use Devices June 2007.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
Office of Research Oversight 1 Office of Research and Development Local Accountability Meeting January 2009.
1 Auditing and Monitoring Gerald Beccia/RCO VA CT Healthcare System.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Office of Research Oversight Office of Research Oversight 1 Human Subject Protection Issues for HSR&D Researchers Tom Puglisi, PhD, CIP Chief Research.
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.
Office of Research Oversight What’s New in VHA Handbook Dated November 15, 2011 December 1, 2011.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
GCP (GOOD CLINICAL PRACTISE)
Main Line Hospitals Institutional Review Board Unanticipated Problems Anne Marie Hobson, BSN, JD, ORA Director Theresa Greaves, ORA Manager.
Bussara Sukpanichnant, Human Subject Protection Office, USAMD-AFRIMS Unanticipated Problems 15 th FERCAP International Conference 24 Nov 15 Nagasaki, Japan.
Unanticipated Problems Involving Risks to Subjects or Others (UPIRSO)
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Dartmouth Human Research Protection Program (HRPP) Data Safety Monitoring and Reporting requirements Brown Bag Series: Noon / First Tuesday of the Month.
IRB reporting updates.
What is a Data and Safety Monitoring Plan and how do I get one?
Reportable Events & Other IRB Updates February 2017
Pharmacovigilance in clinical trials
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Navigating Non-Compliance
SERIOUS ADVERSE EVENTS REPORTING
Unanticipated Problems Involving Risks to Subjects or Others (UPIRSO)
HHS Reporting Requirements and Adverse Events
Event Reporting in Human Subjects Research
Research with Human Subjects
Presentation transcript:

Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research Oversight (ORO)

Office of Research Oversight ORO What is a Handbook? Handbooks are part of the VA directives management system that contain mandated procedures for implementing policy

Office of Research Oversight ORO PURPOSE OF HANDBOOK Sets out the requirements for reporting certain adverse events in research to ORO

Office of Research Oversight ORO NOTE: Handbook does NOT replace or change any of the applicable adverse event reporting requirements for VA, other agencies (federal or state) and/or commercial sponsors

Office of Research Oversight ORO Goals of the new reporting requirements Facilitate ORO’s oversight of adverse events in VA research Specify –Which adverse events to report to ORO –Details to be reported –Timeline for reporting Collect information to provide better oversight Assist IRBs in taking appropriate action

Office of Research Oversight ORO What do the VA regulations on research require with respect to reporting adverse events?

Office of Research Oversight ORO 38 CFR (b) …Assurances applicable to federally supported or conducted research shall at a minimum include: (5) Written procedures for ensuring prompt reporting to the IRB, appropriate institutional officials, and the department or agency head of (i) any unanticipated problems involving risks to subjects or others….

Office of Research Oversight ORO Application of the regulation to the operation of an institution’s HRPP and IRB There should be detailed instructions on how to report and manage adverse events in SOPs that are also consistent with all relevant regulations and VHA policies, including National Patient Safety Improvement Handbook (1050.1)

Office of Research Oversight ORO What are the contents of this new Handbook? New, more narrowly defined requirements for reporting research adverse events to ORO. IMPORTANT: these requirements are ONLY for reporting adverse events to ORO and do not relate to any other reporting requirements

Office of Research Oversight ORO NEW – each VHA facility must report to the appropriate ORO Regional Office (RO) all AEs (or imminent threats of) in research that meet specific criteria - new definitions specific to Handbook

Office of Research Oversight ORO Definitions specific to new Handbook Adverse Event in Research (AE) – any untoward occurrence (physical, psychological, social or economic) in a human subject participating in research. any unfavorable or unintended event including abnormal laboratory finding, symptom, disease, or death associated with the research or the use of a medical test article. may occur even in the absence of any error or protocol deviation, and does not necessarily have to be caused by any identifiable aspect of the research.

Office of Research Oversight ORO Definitions specific to new Handbook Imminent Threat of an AE in Research – Any situation in which an AE in research has not yet occurred but is very likely to occur without preventative measures determination of imminent threat can be made by an IRB, research or clinical team member

Office of Research Oversight ORO Definitions specific to new Handbook Substantive Action – Action taken by an IRB 1] That materially alters substance and meaning of a protocol informed consent form or process investigator status, including (but not limited to) restriction, suspension or termination of a study or investigator participation 2] To prevent future occurrence(s) of the adverse event

Office of Research Oversight ORO Definitions specific to new Handbook Unexpected Death – Death of a research subject in a trial in which a high risk of death is not projected, as indicated by the written protocol, informed consent form, and/or sponsor brochure NOTE: Does not include death from terminal condition unless clearly hastened by research intervention clearly not associated with the research

Office of Research Oversight ORO New Handbook reporting requirements Each VHA facility must report to appropriate ORO Regional Office all AEs (or imminent threats of) in research conducted on site that result in 1] IRB taking substantive action(s), as defined in this Handbook written report of (imminent threat of) AE in research and IRB actions within 10 working days 2] unexpected death of a research subject, regardless of IRB action report no later than 2 working days after IRB informed of death

Office of Research Oversight ORO Requirements for written report (1) Separate report for each AE (or imminent threat of) in research prepared by institutional official (VHA facility Director) or designee (2) Institutional Official/designee initials report and facilitates submission to ORO RO Director (using express mail and or fax) (3) Copy of IRB minutes from meeting(s) in which AE and subsequent action(s) were discussed, ratified, or summarized accompanies report, or follows within 4 weeks if not immediately available

Office of Research Oversight ORO POINTS TO REMEMBER Definitions of what to report specific to this Handbook (limited to most severe AEs) Reporting limited to events that meet specific criteria also specific to this Handbook Report made to appropriate ORO Regional Office Applies ONLY to reports made to ORO (does NOT affect other reporting responsibilities) Talk will be posted on ORO website